IRLCX
Price
$48.51
Change
+$0.41 (+0.85%)
Updated
Jul 31 closing price
Net Assets
1.06B
RWMFX
Price
$67.92
Change
-$0.03 (-0.04%)
Updated
Jul 31 closing price
Net Assets
219.02B
Interact to see
Advertisement

IRLCX vs RWMFX

IRLCX vs RWMFX Comparison Chart in %
View a ticker or compare two or three
VS
IRLCX vs. RWMFX commentary
Aug 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRLCX is a Buy and RWMFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMFX has more cash in the bank: 219B vs. IRLCX (1.07B). RWMFX pays higher dividends than IRLCX: RWMFX (1.42) vs IRLCX (1.29). IRLCX was incepted earlier than RWMFX: IRLCX (18 years) vs RWMFX (24 years). IRLCX (0.87) is less costly to investors than RWMFX (0.31). RWMFX is a more actively managed with annual turnover of: 29.00 vs. IRLCX (11.00). IRLCX has a lower initial minimum investment than RWMFX: IRLCX (0) vs RWMFX (250). IRLCX annual gain was more profitable for investors over the last year : 13.45 vs. RWMFX (7.01). IRLCX return over 5 years is better than : 62.76 vs. RWMFX (28.79).
IRLCXRWMFXIRLCX / RWMFX
Total Expense Ratio0.610.31197%
Annual Report Gross Expense Ratio0.870.31281%
Fund Existence18 years24 years-
Gain YTD3.9485.01879%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B219B0%
Annual Yield % from dividends1.291.4291%
Returns for 1 year13.457.01192%
Returns for 3 years59.8028.01213%
Returns for 5 years62.7628.79218%
Returns for 10 years231.4280.69287%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSENX85.940.70
+0.82%
Fidelity Select Energy Portfolio
BAUUX32.460.07
+0.22%
Brown Advisory Small-Cap Fdmtl Val Instl
GSIMX24.30N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps Instl
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
RYBOX71.28-1.65
-2.26%
Rydex Biotechnology A